Related Experiment Video
Updated: Apr 2, 2026
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
The New Molecular Landscape of Cushing's Disease
Silviu Sbiera1, Timo Deutschbein1, Isabel Weigand1
1Department of Internal Medicine I, Endocrine and Diabetes Unit, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.
Abstract:
Cushing's disease (CD) is caused by corticotropin-secreting pituitary adenomas and results in substantial morbidity and mortality. Its molecular basis has remained poorly understood until the past few years, when several proteins and genes [such as testicular orphan nuclear receptor 4 (TR4) and heat shock protein 90 (HSP90)] were found to play key roles in the disease. Most recently, mutations in the gene of ubiquitin-specific peptidase 8 (USP8) increasing its deubiquination activity were discovered in a high percentage of corticotroph adenomas. Here, we will discuss emerging insights in the molecular alterations that finally result in CD. The therapeutic potential of these findings needs to be carefully evaluated in the near future, hopefully resulting in new treatment options for this devastating disorder.
Insights
Cushing's disease, a disorder caused by pituitary tumors, is increasingly understood at the molecular level. Recent findings highlight the role of USP8 gene mutations in its development, offering hope for new treatments.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Cushing's disease (CD) results from corticotropin-secreting pituitary adenomas, leading to significant morbidity and mortality.
- The molecular underpinnings of CD have been historically unclear, but recent discoveries are shedding light on key genetic and protein factors.
- Previously identified genes like testicular orphan nuclear receptor 4 (TR4) and heat shock protein 90 (HSP90) are known to be involved.
Purpose of the Study:
- To review and discuss recent advancements in understanding the molecular alterations driving Cushing's disease.
- To highlight the significance of newly discovered genetic mutations in the pathogenesis of corticotroph adenomas.
- To explore the potential therapeutic implications of these molecular insights for Cushing's disease.
Main Methods:
- Literature review of recent studies on the molecular basis of Cushing's disease.
- Analysis of genetic and protein data related to pituitary adenomas.
- Discussion of emerging molecular findings and their clinical relevance.
Main Results:
- Mutations in the ubiquitin-specific peptidase 8 (USP8) gene have been identified in a significant proportion of corticotroph adenomas.
- These USP8 mutations enhance deubiquitination activity, contributing to the development of CD.
- Emerging research points to specific molecular pathways and genetic factors underlying CD.
Conclusions:
- Recent molecular discoveries, particularly USP8 mutations, have significantly advanced the understanding of Cushing's disease.
- These findings offer promising avenues for developing novel therapeutic strategies.
- Further evaluation is needed to translate these molecular insights into effective treatments for CD.
Related Concept Videos
02:17The Tumor Microenvironment
02:23Abnormal Proliferation
01:27Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...